Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications
Wei Liu(Second People’s Hospital of Yibin), Aleksandra A. Pandyra(Heinrich Heine University Düsseldorf), Dieter Häussinger(Heinrich Heine University Düsseldorf), Nikkitha Umesh Ganesh, Karl S. Lang(Essen University Hospital), Bernhard Homey(Düsseldorf University Hospital), Paweł Stachura(Heinrich Heine University Düsseldorf), Ruifeng Wang(Nanjing Agricultural University), Haifeng C. Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Fiona Cox(Heinrich Heine University Düsseldorf), Jay Gopalakrishnan(University of Cologne), Philipp A. Lang(Heinrich Heine University Düsseldorf)
Cited by 51
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization
|Journal of Neuroinflammation|2020|609